HGF and cancer: In vitro wound-healing tests evaluating the effect of tepotinib, with or without HGF, on closure of a gap induced by scratching a layer of NCI-H441 lung cancer cells demonstrated that tepotinib inhibits cancer cell migration at clinically relevant concentrations (30).